Indian F&O data, and the evidence about what not to trade · educational
📡 Radar📜 Earnings🌦️ Weather🌡️ Volatility🏭 Sectors🧭 Crowd📈 Extremes🔬 Myths🛡 Scorecard

MANKIND · Healthcare

Price
₹2,309.0
1M / 3M / 1Y
-5.3% / -2.7% / -13.2%
20d realized vol
18%
Traded value (60d med)
₹79 cr
Delivery % (20d avg)
58%
Days in F&O ban since 2020
0
Futures OI / 1d change
2.9M / -0.1M
PCR / basis
0.67 / +0.06%
ATM implied vol
22% (vs 18% realized)

📜 Results-day history

Typical move 2.6% · up on the day 57% of 7 events · moved 4%+ in 14% · worst -2.7% / best +9.1%

Reaction dayMoveOpen gapNext 5dAnnounced
2026-07-22-1.3%-0.6%+1.9%after close
2026-04-21+2.6%+0.3%+2.9%during mkt
2026-01-21-1.2%+0.0%+0.8%after close
2025-10-16+0.4%+0.5%-0.2%after close
2025-07-23-2.7%+0.2%-0.9%after close
2023-08-03+9.1%+9.2%-3.0%after close
2023-06-01+2.6%+0.6%+4.4%after close
Educational data reference: NOT investment advice. Historical statistics do not predict future results. We are not SEBI-registered advisers. All data from NSE public sources; figures may contain errors. Trading, especially leveraged F&O, can cause significant losses.
1KSG Terminal · data from NSE public archives · regenerated nightly